TP53 and neoplasm: In summary, we demonstrate that induction of KRASG12D and co-occurring mutant p53 expression in the lung produces highly proliferative lung tumors that can be reduced by abrogating KRASG12D expression, genetically or chemically, resulting in fewer pulmonary lesions, likely due to apoptotic cell death of tumor cells.